The stock of Inflarx N.V. (NASDAQ:IFRX) registered a decrease of 1.57% in short interest. IFRX’s total short interest was 231,600 shares in January as published by FINRA. Its down 1.57% from 235,300 shares, reported previously. With 11,900 shares average volume, it will take short sellers 20 days to cover their IFRX’s short positions. The short interest to Inflarx N.V.’s float is 3.2%.
The stock increased 1.73% or $0.6 during the last trading session, reaching $35.62. About 1,651 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 63.49% since January 23, 2018 and is uptrending. It has outperformed by 63.49% the S&P500.
InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $914.21 million. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.
More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Nasdaq.com which released: “Increased and final cash offer for Faroe Petroleum plc by DNO ASA – Nasdaq” on January 08, 2019, also Nasdaq.com with their article: “Cnova NV : Full Year 2018 Activity and Net Sales – Nasdaq” published on January 11, 2019, Globenewswire.com published: “InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa – GlobeNewswire” on November 08, 2018. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Benzinga.com and their article: “50 Biggest Movers From Monday – Benzinga” published on January 02, 2019 as well as Nasdaq.com‘s news article titled: “Pulse Seismic Inc. Announces Acquisition of Seitel Canada Ltd. – Nasdaq” with publication date: January 15, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.